NCT04714411View on ClinicalTrials.gov

Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

August 18, 2025

Study Completion Date

August 18, 2025

Conditions
Diabetic Foot Infection
Interventions
DRUG

Omadacycline

Omadacycline monotgherapy

Trial Locations (2)

75203

RECRUITING

Methodist Dallas Medical Center, Dallas

75237

NOT_YET_RECRUITING

Methodist Charlton Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER